Mylan (MYL) Holdings Decreased by First Dallas Securities Inc.
First Dallas Securities Inc. decreased its stake in shares of Mylan (NASDAQ:MYL) by 40.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 22,075 shares of the company’s stock after selling 14,955 shares during the quarter. First Dallas Securities Inc.’s holdings in Mylan were worth $934,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of the business. Meeder Asset Management Inc. increased its holdings in shares of Mylan by 76.9% during the 3rd quarter. Meeder Asset Management Inc. now owns 3,393 shares of the company’s stock worth $106,000 after acquiring an additional 1,475 shares during the last quarter. BT Investment Management Ltd acquired a new position in shares of Mylan during the 3rd quarter worth approximately $142,000. Advisor Partners LLC acquired a new position in shares of Mylan during the 4th quarter worth approximately $214,000. First Personal Financial Services increased its holdings in shares of Mylan by 77.1% during the 4th quarter. First Personal Financial Services now owns 4,839 shares of the company’s stock worth $205,000 after acquiring an additional 2,106 shares during the last quarter. Finally, Mycio Wealth Partners LLC acquired a new position in shares of Mylan during the 4th quarter worth approximately $212,000. 75.56% of the stock is currently owned by hedge funds and other institutional investors.
In other news, CEO Heather M. Bresch sold 75,000 shares of the business’s stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $45.00, for a total transaction of $3,375,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.69% of the stock is currently owned by insiders.
Several analysts recently issued reports on MYL shares. Mizuho restated a “buy” rating and issued a $37.00 price target on shares of Mylan in a research note on Tuesday, October 24th. Zacks Investment Research downgraded Mylan from a “buy” rating to a “hold” rating in a research note on Wednesday, November 8th. Cantor Fitzgerald set a $41.00 price target on Mylan and gave the company a “hold” rating in a research note on Tuesday, December 26th. UBS Group set a $46.00 price target on Mylan and gave the company a “buy” rating in a research note on Monday, December 4th. Finally, Susquehanna Bancshares reiterated a “positive” rating and set a $55.00 target price (up from $47.00) on shares of Mylan in a research report on Thursday, January 25th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company. Mylan currently has an average rating of “Buy” and a consensus target price of $44.65.
COPYRIGHT VIOLATION NOTICE: This news story was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another site, it was copied illegally and republished in violation of United States & international copyright & trademark laws. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2018/02/12/mylan-myl-holdings-decreased-by-first-dallas-securities-inc.html.
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan (NASDAQ:MYL).
Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.